Results 251 to 260 of about 369,446 (359)
A practical guide to the updated seizure classification 2025
Abstract This paper provides a practical guide to applying the updated seizure classification in clinical settings. The updated classification, published by the International League Against Epilepsy in 2025, builds on the operational classification introduced in 2017.
Sándor Beniczky +22 more
wiley +1 more source
Cuproptosis and Immune Microenvironment Interplay in Temporal Lobe Epilepsy: Identification of Key Molecular Signatures and Therapeutic Targets. [PDF]
Li W +5 more
europepmc +1 more source
Exploring the role of apolipoprotein ε4 in progressive myoclonic epilepsy type 1
Abstract Objective Progressive myoclonic epilepsy type 1 (EPM1) is a neurodegenerative disease caused by biallelic variants in the cystatin B (CSTB) gene. Despite a progressive course, phenotype severity varies among patients, even within families. We studied the potential role of APOE ε4 in modifying phenotypic diversity in EPM1, given its established
Janina Gunnar +10 more
wiley +1 more source
Features of cognitive dysfunction in late-onset temporal lobe epilepsy. [PDF]
Hasegawa N, Saito N, Fukuda M.
europepmc +1 more source
Abstract Objective Neurocysticercosis (NCC) is a common parasitic infection of the central nervous system and a known cause of focal epilepsy. Its potential role in triggering or contributing to mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE‐HS) is suggested, but the impact on brain volumetry remains unclear.
Jaisa Quedi Araújo +10 more
wiley +1 more source
Correction: Induced Overexpression of Connexin43 in Astrocytes Attenuates the Progression of Experimental Temporal Lobe Epilepsy. [PDF]
Kherbouche O +8 more
europepmc +1 more source

